|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
JPH0742304B2
(ja)
|
1986-12-05 |
1995-05-10 |
財団法人微生物化学研究会 |
新規なアンスラサイクリン誘導体およびその製造法
|
|
WO1988007089A1
(en)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Altered antibodies
|
|
DE3712350A1
(de)
|
1987-04-11 |
1988-10-20 |
Behringwerke Ag |
Semisynthetische rhodomycine, verfahren zu ihrer herstellung und ihre verwendung als zytostatika
|
|
EP0335369A3
(en)
|
1988-03-29 |
1990-03-28 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
New anthracycline derivatives and processes for the preparation of the same
|
|
US5047335A
(en)
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
|
ES2096590T3
(es)
|
1989-06-29 |
1997-03-16 |
Medarex Inc |
Reactivos biespecificos para la terapia del sida.
|
|
EP0533744A1
(en)
|
1990-06-11 |
1993-03-31 |
Biochem Pharma Inc. |
Heterocyclic anthracyclione and anthracycline analogs
|
|
DE69132709T2
(de)
|
1990-06-29 |
2002-06-20 |
Large Scale Biology Corp., Vacaville |
Melaninproduktion durch transformierte mikroorganismen
|
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
|
US5192880A
(en)
|
1990-11-13 |
1993-03-09 |
Nec Corporation |
High-speed emitter coupled logic circuit with large current driving capability
|
|
KR100211417B1
(ko)
|
1990-11-30 |
1999-10-01 |
유충식 |
L-탈로피라노시드 유도체 및 그의 제조방법
|
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
|
NZ241606A
(en)
|
1991-02-28 |
1994-08-26 |
Iaf Biochem Int |
Heteroanthracycline antitumor analogs, preparation and pharmaceutical compositions thereof; intermediates therefor
|
|
JP3025056B2
(ja)
|
1991-03-12 |
2000-03-27 |
財団法人微生物化学研究会 |
２，６−ジデオキシ−２−フルオロ−ｌ−タロピラノース誘導体の製造法
|
|
US5278299A
(en)
|
1991-03-18 |
1994-01-11 |
Scripps Clinic And Research Foundation |
Method and composition for synthesizing sialylated glycosyl compounds
|
|
JPH04290891A
(ja)
|
1991-03-19 |
1992-10-15 |
Yasumitsu Tamura |
新規なアンスラサイクリン系化合物
|
|
DE4111971C1
(https=)
|
1991-04-12 |
1992-03-12 |
Wolf-Dieter Dr. 7803 Gundelfingen De Fessner |
|
|
US5552534A
(en)
|
1991-08-22 |
1996-09-03 |
The Trustees Of The University Of Pennsylvania |
Non-Peptide peptidomimetics
|
|
FI941572L
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
|
|
EP0642526B1
(en)
|
1991-10-15 |
1998-12-23 |
The Scripps Research Institute |
Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of gdp-fucose
|
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
|
WO1993010260A1
(en)
|
1991-11-21 |
1993-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases
|
|
AU675929B2
(en)
|
1992-02-06 |
1997-02-27 |
Curis, Inc. |
Biosynthetic binding protein for cancer marker
|
|
US5278311A
(en)
|
1992-06-05 |
1994-01-11 |
E. R. Squibb & Sons, Inc. |
Nonionic radiographic contrast agents
|
|
US5736523A
(en)
|
1992-11-09 |
1998-04-07 |
Biochem Pharma Inc. |
Antineoplastic heteronapthoquinones
|
|
DK76193D0
(da)
|
1993-06-25 |
1993-06-25 |
Astra Ab |
Kulhydratderivater
|
|
ATE207966T1
(de)
|
1993-09-13 |
2001-11-15 |
Canon Kk |
Bestimmung von nukleinsäuren durch pcr, messung der anzahl von mikrobiellen zellen, genen oder genkopien durch pcr und kit zu ihrer verwendung
|
|
GB9418260D0
(en)
|
1994-09-09 |
1994-10-26 |
Erba Carlo Spa |
Anthracycline derivatives
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
JPH08286368A
(ja)
|
1995-04-14 |
1996-11-01 |
Toyo Ink Mfg Co Ltd |
着色画像形成材料およびそれを用いた着色画像形成媒体と着色画像形成方法
|
|
US6245347B1
(en)
|
1995-07-28 |
2001-06-12 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
|
EP0761678B1
(en)
|
1995-09-08 |
1999-03-31 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Fluorine-containing anthracycline derivatives having hydroxyl group(s) mono- or di-o-aminoalkanoylated in the sugar moiety thereof
|
|
DE19541260A1
(de)
|
1995-11-06 |
1997-05-07 |
Lohmann Therapie Syst Lts |
Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
|
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
|
PL182601B1
(pl)
|
1996-07-17 |
2002-02-28 |
Waldpharm Sp Z Oo |
Sposób otrzymywania antybiotyków antracyklinowych
|
|
DE19640969A1
(de)
|
1996-10-04 |
1998-04-16 |
Bayer Ag |
20-0-verknüpfte Glycokonjugate von Camptothecin
|
|
US5770407A
(en)
|
1996-12-10 |
1998-06-23 |
The Scripps Research Institute |
Process for preparing nucleotide inhibitors of glycosyltransferases
|
|
FR2764304B1
(fr)
|
1997-06-06 |
1999-07-16 |
Rhone Poulenc Rorer Sa |
Nouvelle classe d'agents transfectants cationiques des acides nucleiques
|
|
JPH1135593A
(ja)
|
1997-07-18 |
1999-02-09 |
Daikin Ind Ltd |
２−フルオロフコシル−ｎ−アロイルグルコサミン誘導体及びその中間物、並びにそれらの製造方法
|
|
US6248864B1
(en)
|
1997-12-31 |
2001-06-19 |
Adherex Technologies, Inc. |
Compounds and methods and modulating tissue permeability
|
|
ES2434961T5
(es)
|
1998-04-20 |
2018-01-18 |
Roche Glycart Ag |
Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo
|
|
US6312717B1
(en)
|
1998-07-07 |
2001-11-06 |
Bristol-Myers Squibb Company |
Method for treatment of anxiety and depression
|
|
SE9802864D0
(sv)
|
1998-08-27 |
1998-08-27 |
Pharmacia & Upjohn Ab |
Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
|
|
WO2000046750A1
(en)
|
1999-02-05 |
2000-08-10 |
Samsung Electronics Co., Ltd. |
Image texture retrieving method and apparatus thereof
|
|
EP1176195B1
(en)
|
1999-04-09 |
2013-05-22 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
|
US6544548B1
(en)
|
1999-09-13 |
2003-04-08 |
Keraplast Technologies, Ltd. |
Keratin-based powders and hydrogel for pharmaceutical applications
|
|
US20080050809A1
(en)
|
1999-09-28 |
2008-02-28 |
Alejandro Abuin |
Novel human kinases and polynucleotides encoding the same
|
|
US20040219521A1
(en)
|
2000-01-21 |
2004-11-04 |
Tang Y. Tom |
Novel nucleic acids and polypeptides
|
|
FR2807767B1
(fr)
|
2000-04-12 |
2005-01-14 |
Lab Francais Du Fractionnement |
Anticorps monoclonaux anti-d
|
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
US6670330B1
(en)
|
2000-05-01 |
2003-12-30 |
Theodore J. Lampidis |
Cancer chemotherapy with 2-deoxy-D-glucose
|
|
US6696081B2
(en)
|
2000-06-09 |
2004-02-24 |
Duke University |
Carbohydrate based lipid compositions and supramolecular structures comprising same
|
|
AU2001281886A1
(en)
|
2000-06-26 |
2002-01-08 |
Basf Aktiengesellschaft |
Phosphacyclohexanes and the use thereof in the hydroformylation of olefins
|
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
|
EP2180044A1
(en)
|
2001-08-03 |
2010-04-28 |
GlycArt Biotechnology AG |
Antibody glycosylation variants having increased anti-body-dependent cellular cytotoxicity
|
|
EP1504099A4
(en)
|
2001-12-10 |
2006-05-10 |
Nuvelo Inc |
NEW NUCLEIC ACIDS AND POLYPEPTIDES
|
|
WO2003068943A2
(en)
|
2002-02-13 |
2003-08-21 |
Incyte Corporation |
Secreted proteins
|
|
EP2388265A1
(en)
|
2002-02-22 |
2011-11-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
AUPS247502A0
(en)
|
2002-05-22 |
2002-06-13 |
Griffith University |
An antimicrobial agent
|
|
US20040121370A1
(en)
|
2002-09-11 |
2004-06-24 |
Genentech, Inc. |
Novel composition and methods for the treatment of immune related diseases
|
|
EP2116551A1
(en)
|
2002-09-11 |
2009-11-11 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
WO2004032845A2
(en)
|
2002-10-07 |
2004-04-22 |
Encore Pharmaceuticals, Inc. |
R-nsaid esters and their use
|
|
AU2004213053C1
(en)
|
2003-02-20 |
2009-07-16 |
Seagen Inc. |
Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
|
WO2004091499A2
(en)
|
2003-04-09 |
2004-10-28 |
Neose Technologies, Inc. |
Intracellular formation of peptide conjugates
|
|
CN1835962A
(zh)
|
2003-06-03 |
2006-09-20 |
加利福尼亚大学董事会 |
利用乙酰化二糖治疗疾病的组合物与方法
|
|
FR2858235B1
(fr)
|
2003-07-31 |
2006-02-17 |
Lab Francais Du Fractionnement |
Utilisation d'anticorps optimises en adcc pour traiter les patients faibles repondeurs
|
|
EP1687291A4
(en)
|
2003-11-17 |
2009-01-07 |
Aromagen Corp |
NEW CYCLIC OXYGENIZED COMPOUNDS OF COOLING AS WELL AS FRAGRANCE AND TASTE PROPERTIES, AND APPLICATIONS THEREFOR
|
|
WO2005061523A1
(en)
|
2003-12-23 |
2005-07-07 |
Progen Industries Limited |
Glycosaminoglycan (gag) mimetics
|
|
PL369253A1
(pl)
|
2004-07-23 |
2006-02-06 |
Zakład Badawczo-Produkcyjny SYNTEX Sp.z o.o. |
Sposób otrzymywania złożonych 2-deoksy-2-jodopiranozydów o wysokiej czystości, szczególnie Annamycyny o czystości farmaceutycznej
|
|
BRPI0513959A
(pt)
|
2004-07-30 |
2008-05-20 |
Rinat Neuroscience Corp |
anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos
|
|
WO2006040558A1
(en)
|
2004-10-15 |
2006-04-20 |
Astrazeneca Ab |
Substituted adenines and the use thereof
|
|
EP1810035A4
(en)
|
2004-11-10 |
2010-03-17 |
Macrogenics Inc |
GENERATION OF FC ANTIBODY REGIONS FOR EFFECTOR FUNCTION
|
|
EP3214095B1
(en)
|
2005-05-12 |
2019-12-11 |
ZymoGenetics, Inc. |
Compositions and methods for modulating immune responses
|
|
CA2609269C
(en)
|
2005-05-26 |
2014-08-05 |
Seattle Genetics, Inc. |
Humanized anti-cd40 antibodies and their methods of use
|
|
EP1963534A2
(en)
|
2005-12-19 |
2008-09-03 |
Genizon Biosciences Inc. |
Genemap of the human gene associated with crohn's disease
|
|
AU2007220777A1
(en)
|
2006-02-24 |
2007-09-07 |
Board Of Regents, The University Of Texas System |
Hexose compounds to treat cancer
|
|
US8242167B2
(en)
|
2006-02-24 |
2012-08-14 |
University Of Miami |
Mannose derivatives for killing tumor cells
|
|
US20100075377A1
(en)
|
2006-04-13 |
2010-03-25 |
West James W |
Tetramerizing polypeptides and methods of use
|
|
EP2004682A2
(en)
|
2006-04-13 |
2008-12-24 |
Zymogenetics, Inc. |
Tetramerizing polypeptides and methods of use
|
|
US9149489B2
(en)
|
2006-04-27 |
2015-10-06 |
Board Of Regents, University Of Texas System |
Inhibitors of glycolysis useful in the treatment of brain tumors
|
|
EP2520935A3
(en)
|
2006-08-09 |
2013-02-13 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
DE102006053637B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
DE102006053635B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
WO2008070593A2
(en)
|
2006-12-01 |
2008-06-12 |
Seattle Genetics, Inc. |
Variant target binding agents and uses thereof
|
|
WO2008131024A1
(en)
|
2007-04-17 |
2008-10-30 |
Board Of Regents, The University Of Texas System |
Iodo-hexose compounds useful to treat cancer
|
|
GB0714514D0
(en)
*
|
2007-07-26 |
2007-09-05 |
Univ City |
Computer system
|
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
US8691730B2
(en)
|
2007-09-14 |
2014-04-08 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
KR101662622B1
(ko)
|
2007-10-04 |
2016-10-05 |
지모제넥틱스, 인코포레이티드 |
Ｂ7 패밀리 구성원 ｚＢ7Ｈ6 및 관련된 조성물 및 방법
|
|
US8293720B2
(en)
|
2007-12-20 |
2012-10-23 |
Dogwood Pharmaceuticals, Inc. |
Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
|
CN101998963B
(zh)
|
2008-02-12 |
2014-09-24 |
陶氏益农公司 |
杀虫组合物
|
|
JP5260093B2
(ja)
|
2008-03-10 |
2013-08-14 |
クラレノリタケデンタル株式会社 |
重合性単量体、重合性組成物及び歯科用材料
|
|
CA2978149C
(en)
|
2008-03-21 |
2019-02-12 |
The General Hospital Corporation |
Inositol derivatives for the detection and treatment of alzheimer's disease and related disorders
|
|
CN101555262A
(zh)
|
2008-04-08 |
2009-10-14 |
中国科学院生态环境研究中心 |
六水合三氯化铁(FeCl3·6H2O)选择性脱除糖类化合物异头碳酰基的方法
|
|
EP3208612B1
(en)
|
2008-04-09 |
2019-09-18 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US8163551B2
(en)
|
2008-05-02 |
2012-04-24 |
Seattle Genetics, Inc. |
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
|
|
EP2303282A4
(en)
|
2008-05-23 |
2013-02-13 |
Univ Miami |
TREATMENT WITH CONTINUOUS LOW DOSED APPLICATION OF SUGAR ANALOGUE
|
|
JP5771154B2
(ja)
|
2009-02-11 |
2015-08-26 |
ダウ アグロサイエンシィズ エルエルシー |
殺虫剤組成物
|
|
AU2010225456B2
(en)
|
2009-03-18 |
2016-03-17 |
Carina Biotech Pty Ltd |
Biomarkers and uses thereof
|
|
WO2010111713A2
(en)
|
2009-03-27 |
2010-09-30 |
Zacharon Pharmaceuticals, Inc. |
N-linked glycan biosynthesis modulators
|
|
US9034341B2
(en)
|
2009-04-20 |
2015-05-19 |
Transtech Pharma, Llc |
Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions
|
|
US9624255B2
(en)
|
2009-08-11 |
2017-04-18 |
Arizona Board Of Regents |
Carbohydrate-mediated tumor targeting
|
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
|
EP2566876A4
(en)
|
2010-05-06 |
2014-01-08 |
Univ Fraser Simon |
METHOD AND COMPOUNDS FOR INHIBITING GLYCOSYL TRANSFERASES
|
|
US8822642B2
(en)
|
2010-06-09 |
2014-09-02 |
Zymogenetics, Inc. |
Dimeric fusion proteins and related compositions and methods
|
|
DK2593594T3
(en)
|
2010-07-16 |
2017-12-11 |
Adimab Llc |
ANTIBODY LIBRARIES
|
|
DK2608796T3
(en)
|
2010-08-05 |
2019-03-18 |
Seattle Genetics Inc |
Inhibition of protein fucosylation in vivo using fucose analogues
|
|
US9394555B2
(en)
|
2010-08-12 |
2016-07-19 |
Novozymes, Inc. |
Compositions comprising a polypeptide having cellulolytic enhancing activity and a dioxy compound and uses thereof
|
|
TWI410431B
(zh)
|
2010-12-22 |
2013-10-01 |
Ind Tech Res Inst |
齊敦果酸衍生物在製備預防或治療ｃ型肝炎之藥物的用途
|
|
US8923278B2
(en)
|
2011-01-10 |
2014-12-30 |
Vtech Telecommunications Limited |
Peer-to-peer, internet protocol telephone system with system-wide configuration data
|
|
CA2824175A1
(en)
|
2011-01-11 |
2012-07-19 |
The University Of Texas M.D. Anderson Cancer |
Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases
|
|
US9493452B2
(en)
|
2011-03-24 |
2016-11-15 |
Southern Methodist University |
Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
|
|
SG195086A1
(en)
|
2011-05-31 |
2013-12-30 |
Merck Patent Gmbh |
Compounds containing hydrido-tricyano-borate anions
|
|
EP2731955B1
(en)
|
2011-07-15 |
2017-01-11 |
Merck Patent GmbH |
Compounds containing alkyl-cyano-borate or alkyl-cyano-fluoroborate anions
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
CA3215250A1
(en)
|
2012-03-13 |
2013-09-19 |
Salk Institute For Biological Studies |
Selective cell targeting using adenovirus and chemical dimers
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
AU2013243948A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US10722577B2
(en)
|
2012-05-25 |
2020-07-28 |
Sloan Kettering Institute For Cancer Research |
Methods for treating GI syndrome and graft versus host disease
|
|
MX2014014951A
(es)
|
2012-06-06 |
2015-03-13 |
Oncomed Pharm Inc |
Agentes aglutinantes que modulan la trayectoria hippo y sus usos.
|
|
CN104968364A
(zh)
|
2012-12-03 |
2015-10-07 |
百时美施贵宝公司 |
强化免疫调变性Fc融合蛋白的抗癌活性
|
|
HK1210964A1
(en)
|
2012-12-04 |
2016-05-13 |
Oncomed Pharmaceuticals, Inc. |
Immunotherapy with binding agents
|
|
CN104250302B
(zh)
|
2013-06-26 |
2017-11-14 |
上海君实生物医药科技股份有限公司 |
抗pd‑1抗体及其应用
|
|
CA2916681A1
(en)
|
2013-07-16 |
2015-01-22 |
Genentech, Inc. |
Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors
|
|
US10077305B2
(en)
|
2013-09-10 |
2018-09-18 |
Medimmune Limited |
Antibodies against PD-1 and uses thereof
|
|
WO2015061668A1
(en)
|
2013-10-25 |
2015-04-30 |
Dana-Farber Cancer Institute, Inc. |
Anti-pd-l1 monoclonal antibodies and fragments thereof
|
|
WO2015073682A1
(en)
|
2013-11-13 |
2015-05-21 |
Oregon Health And Science University |
Methods of detecting cells latently infected with hiv
|
|
RS63295B1
(sr)
*
|
2013-12-24 |
2022-06-30 |
Janssen Pharmaceutica Nv |
Anti-vista antitela i fragmenti
|
|
WO2015143343A2
(en)
|
2014-03-21 |
2015-09-24 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring
|
|
SG11201700258VA
(en)
|
2014-07-16 |
2017-02-27 |
Genentech Inc |
Methods of treating cancer using tigit inhibitors and anti-cancer agents
|
|
AU2015305754B2
(en)
|
2014-08-19 |
2018-10-25 |
Merck Sharp & Dohme Llc |
Anti-tigit antibodies
|
|
CA2963720C
(en)
|
2014-10-29 |
2024-05-14 |
Seattle Genetics, Inc. |
Dosage and administration of non-fucosylated anti-cd40 antibodies
|
|
KR20170072343A
(ko)
|
2014-11-06 |
2017-06-26 |
제넨테크, 인크. |
Ox40 결합 효능제 및 tigit 억제제를 포함하는 병용 요법
|
|
WO2016073879A2
(en)
|
2014-11-06 |
2016-05-12 |
Scholar Rock, Inc. |
Transforming growth factor-related antibodies and uses thereof
|
|
CN107207597A
(zh)
|
2014-11-06 |
2017-09-26 |
儿研所儿童医学中心 |
用于癌症和自身免疫疾病的免疫疗法
|
|
DK3220927T3
(en)
|
2014-11-20 |
2022-02-14 |
Promega Corp |
Systems and methods for assessing modulators of immune checkpoints
|
|
TWI595006B
(zh)
|
2014-12-09 |
2017-08-11 |
禮納特神經系統科學公司 |
抗ｐｄ－１抗體類和使用彼等之方法
|
|
EP3916017A1
(en)
|
2014-12-22 |
2021-12-01 |
PD-1 Acquisition Group, LLC |
Anti-pd-1 antibodies
|
|
CN107207594B
(zh)
*
|
2014-12-23 |
2019-05-07 |
百时美施贵宝公司 |
针对tigit的抗体
|
|
EP3247408A4
(en)
|
2015-01-20 |
2018-08-22 |
Immunexcite, Inc. |
Compositions and methods for cancer immunotherapy
|
|
EP3978929A1
(en)
|
2015-02-19 |
2022-04-06 |
Compugen Ltd. |
Pvrig polypeptides and methods of treatment
|
|
US10227408B2
(en)
|
2015-02-19 |
2019-03-12 |
Compugen Ltd. |
Anti-PVRIG antibodies and methods of use
|
|
WO2016166139A1
(en)
|
2015-04-14 |
2016-10-20 |
Eberhard Karls Universität Tübingen |
Bispecific fusion proteins for enhancing immune responses of lymphocytes against tumor cells
|
|
EP3283508B1
(en)
|
2015-04-17 |
2021-03-17 |
Alpine Immune Sciences, Inc. |
Immunomodulatory proteins with tunable affinities
|
|
US11022615B2
(en)
|
2015-05-04 |
2021-06-01 |
University Of Florida Research Foundation, Inc. |
Regulatory T-cells, method for their isolation and uses
|
|
TWI715587B
(zh)
|
2015-05-28 |
2021-01-11 |
美商安可美德藥物股份有限公司 |
Ｔｉｇｉｔ結合劑和彼之用途
|
|
US11078278B2
(en)
|
2015-05-29 |
2021-08-03 |
Bristol-Myers Squibb Company |
Treatment of renal cell carcinoma
|
|
CA2988119A1
(en)
|
2015-06-03 |
2016-12-08 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce conversion of regulatory t cells into effector t cells for cancer immunotherapy
|
|
JO3620B1
(ar)
|
2015-08-05 |
2020-08-27 |
Amgen Res Munich Gmbh |
مثبطات نقطة فحص مناعية للاستخدام في علاج سرطانات محمولة عبر الدم
|
|
EP3334757A4
(en)
*
|
2015-08-14 |
2019-04-03 |
Merck Sharp & Dohme Corp. |
ANTI-Tigit ANTIBODY
|
|
WO2017040660A1
(en)
|
2015-08-31 |
2017-03-09 |
Oncomed Pharmaceuticals, Inc. |
Combination therapy for treatment of disease
|
|
US20180244783A1
(en)
|
2015-08-31 |
2018-08-30 |
Oncomed Pharmaceuticals, Inc. |
Combination therapy for treatment of disease
|
|
CN108137691B
(zh)
|
2015-09-02 |
2021-10-19 |
耶路撒冷希伯来大学伊萨姆研究发展有限公司 |
特异性针对人类t-细胞免疫球蛋白和itim结构域(tigit)的抗体
|
|
WO2017040945A1
(en)
|
2015-09-04 |
2017-03-09 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use
|
|
JP2018534245A
(ja)
|
2015-09-14 |
2018-11-22 |
アルパイン イミューン サイエンシズ インコーポレイテッド |
調整可能なバリアント免疫グロブリンスーパーファミリードメインおよび改変細胞療法
|
|
EP3349792A1
(en)
|
2015-09-14 |
2018-07-25 |
Compass Therapeutics LLC |
Compositions and methods for treating cancer via antagonism of the cd155/tigit pathway and tgf-
|
|
CA2994858C
(en)
|
2015-09-25 |
2024-01-23 |
Genentech, Inc. |
Anti-tigit antibodies and methods of use
|
|
RU2766200C1
(ru)
|
2015-10-01 |
2022-02-09 |
Хит Байолоджикс, Инк. |
Композиции и способы для соединения внеклеточных доменов типа i и типа ii в качестве гетерологичных химерных белков
|
|
PL3356413T3
(pl)
|
2015-10-01 |
2022-04-19 |
Potenza Therapeutics, Inc. |
Białka anty-tigit wiążące antygen oraz sposoby ich zastosowania
|
|
EP3370768B9
(en)
|
2015-11-03 |
2022-03-16 |
Janssen Biotech, Inc. |
Antibodies specifically binding pd-1 and their uses
|
|
WO2017096274A1
(en)
|
2015-12-04 |
2017-06-08 |
Seattle Genetics, Inc. |
Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor
|
|
WO2017100428A1
(en)
|
2015-12-09 |
2017-06-15 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of using same
|
|
MX2018010445A
(es)
|
2016-03-01 |
2019-10-17 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Anticuerpos especificos del receptor de poliovirus humano (rvp).
|
|
WO2017152088A1
(en)
|
2016-03-04 |
2017-09-08 |
JN Biosciences, LLC |
Antibodies to tigit
|
|
EP3443001B1
(en)
|
2016-04-11 |
2025-04-30 |
Obsidian Therapeutics, Inc. |
REGULATED BIOCIRCUIT SYSTEMS
|
|
IL262365B2
(en)
|
2016-04-15 |
2024-11-01 |
Alpine Immune Sciences Inc |
Immunomodulatory proteins ICOS ligand variants and uses thereof
|
|
EP4706777A2
(en)
|
2016-04-15 |
2026-03-11 |
Alpine Immune Sciences, Inc. |
Cd80 variant immunomodulatory proteins and uses thereof
|
|
EP3452101A2
(en)
|
2016-05-04 |
2019-03-13 |
CureVac AG |
Rna encoding a therapeutic protein
|
|
WO2017193059A1
(en)
|
2016-05-06 |
2017-11-09 |
The Regents Of The University Of California |
Systems and methods for targeting cancer cells
|
|
JP7358047B2
(ja)
|
2016-05-16 |
2023-10-10 |
チェックマブ エス．アール．エル． |
腫瘍浸潤制御性ｔ細胞において選択的に脱制御されたマーカー
|
|
KR102379464B1
(ko)
|
2016-06-20 |
2022-03-29 |
키맵 리미티드 |
항-pd-l1 항체
|
|
CN110088127A
(zh)
|
2016-07-28 |
2019-08-02 |
高山免疫科学股份有限公司 |
Cd155变体免疫调节蛋白及其用途
|
|
US11834490B2
(en)
|
2016-07-28 |
2023-12-05 |
Alpine Immune Sciences, Inc. |
CD112 variant immunomodulatory proteins and uses thereof
|
|
CN110088132B
(zh)
|
2016-08-17 |
2020-10-27 |
康姆普根有限公司 |
抗tigit抗体，抗pvrig抗体及其组合
|
|
CA3034691A1
(en)
|
2016-08-30 |
2018-03-08 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use for treating viral and other infections
|
|
WO2018041120A1
(en)
|
2016-08-31 |
2018-03-08 |
Beijing Biocytogen Co., Ltd |
Genetically modified non-human animal with human or chimeric tigit
|
|
CN116492457A
(zh)
|
2016-09-10 |
2023-07-28 |
耶达研究与开发有限公司 |
降低全身调节性t细胞水平或活性以治疗中枢神经系统的疾病和损伤
|
|
EP3293271A1
(en)
|
2016-09-12 |
2018-03-14 |
The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin |
Marker and target as a diagnostic variable and target for therapy of metastatic cancer
|
|
US20190225701A1
(en)
|
2016-09-26 |
2019-07-25 |
The Brigham And Women's Hospital, Inc. |
Regulators of b cell-mediated immunosuppression
|
|
US10759855B2
(en)
*
|
2016-12-02 |
2020-09-01 |
Rigel Pharmaceuticals, Inc. |
Antigen binding molecules to TIGIT
|
|
EP3589313A4
(en)
*
|
2017-02-28 |
2021-05-19 |
Seagen Inc. |
ANTI-TIGITE ANTIBODY
|
|
JOP20190203A1
(ar)
|
2017-03-30 |
2019-09-03 |
Potenza Therapeutics Inc |
بروتينات رابطة لمولد ضد مضادة لـ tigit وطرق استخدامها
|